newsfilter
← Latest News
GlobeNewswire·

ObsEva Receives Nasdaq Non-Compliance Notice

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland and Boston, MA – August 22, 2022 – ObsEva SA (NASDAQ:OBSV), a biopharmaceutical company developing novel therapies to improve women's reproductive hea